AR048267A1 - Compuestos utiles para el tratamiento de afecciones inflamatorias, alergicas y respiratorias - Google Patents

Compuestos utiles para el tratamiento de afecciones inflamatorias, alergicas y respiratorias

Info

Publication number
AR048267A1
AR048267A1 ARP050101000A ARP050101000A AR048267A1 AR 048267 A1 AR048267 A1 AR 048267A1 AR P050101000 A ARP050101000 A AR P050101000A AR P050101000 A ARP050101000 A AR P050101000A AR 048267 A1 AR048267 A1 AR 048267A1
Authority
AR
Argentina
Prior art keywords
alkyl
group
phenyl
atoms
cycloalkyl
Prior art date
Application number
ARP050101000A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/fr
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of AR048267A1 publication Critical patent/AR048267A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP050101000A 2004-03-17 2005-03-15 Compuestos utiles para el tratamiento de afecciones inflamatorias, alergicas y respiratorias AR048267A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (fr) 2004-03-17 2004-03-17 Dérivés béta-2 agonistes de la phényléthanolamine
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
AR048267A1 true AR048267A1 (es) 2006-04-12

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101000A AR048267A1 (es) 2004-03-17 2005-03-15 Compuestos utiles para el tratamiento de afecciones inflamatorias, alergicas y respiratorias

Country Status (13)

Country Link
KR (1) KR20070026420A (fr)
AP (1) AP2006003743A0 (fr)
AR (1) AR048267A1 (fr)
EC (1) ECSP066854A (fr)
IL (1) IL177754A0 (fr)
MA (1) MA28475B1 (fr)
NL (1) NL1028559C2 (fr)
NO (1) NO20063875L (fr)
PA (1) PA8626401A1 (fr)
PE (1) PE20060123A1 (fr)
SV (1) SV2005002052A (fr)
TW (1) TWI281396B (fr)
UY (1) UY28810A1 (fr)

Also Published As

Publication number Publication date
SV2005002052A (es) 2005-12-13
TW200534846A (en) 2005-11-01
PE20060123A1 (es) 2006-03-08
ECSP066854A (es) 2006-11-24
NO20063875L (no) 2006-09-26
KR20070026420A (ko) 2007-03-08
IL177754A0 (en) 2006-12-31
NL1028559A1 (nl) 2005-09-20
MA28475B1 (fr) 2007-03-01
UY28810A1 (es) 2005-10-31
NL1028559C2 (nl) 2006-04-19
TWI281396B (en) 2007-05-21
AP2006003743A0 (en) 2006-10-31
PA8626401A1 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
AR047510A1 (es) Derivados de sulfonamida como agonistas de receptores adrenergicos ??2
AR044475A1 (es) Derivados de 2-amino -piridina utiles para el tratamiento de enfermedades
AR047509A1 (es) Derivados de sulfonamida como antagonistas de receptores adrenergicos beta2
AR044476A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
AR058546A1 (es) Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1
AR119698A2 (es) Compuesto amida n-urea sustituida derivado de aminoácido
AR069326A1 (es) Derivados bis-(sulfonilamino), proceso de preparacion, composiciones farmaceuticas que los contienen y su uso en terapia.
AR048322A1 (es) Compuestos para el tratamiento de afecciones inflamatorias, alergicas y respiratorias
CR10145A (es) Derivados de tropano útiles en terapia (divisional exp. 6800)
AR037329A1 (es) Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos
AR037676A1 (es) Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulacion; composicion farmaceutica que los comprende y procedimiento para preparar compuestos de formula (i)
AR046394A1 (es) Derivados de quinolinas y quinazolinas, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
AR035617A1 (es) Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios
CO5611128A2 (es) Compuestos derivados de n-aril-2-oxazolidinona-5-carboxamida como agentes antibacteriales
ECSP088479A (es) Derivados de oxadiazol
AR095192A1 (es) Quinolina y quinazolinamidas como modulares de canales de sodio
AR065499A1 (es) Inhibidores de serino proteasas.composiciones farmaceuticas
ATE380818T1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
CO5611152A2 (es) Compuestos derivados piperidina caracterizados por ser antagonistas del receptor de las taquicininas, especialmente del receptor nk1 y composiciones farmaceuticas que los contienen
AR041395A1 (es) Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla
CO5700776A2 (es) Compuestos utiles para el tratamiento de enfermedades
AR067975A1 (es) Derivados de la n-bencil, n-arilcarbonilpiperazina
AR027744A1 (es) Compuestos de eter difenilico utiles en terapia
CO4940505A1 (es) Antagonistas de receptor de benzoxazinona dopamina d 4
CO6241116A2 (es) Pirimidil piperazinas utiles como ligandos del receptor d3/d2

Legal Events

Date Code Title Description
FB Suspension of granting procedure